CytoSorbents Corp. (CTSO)
0.3801
-0.03
(-7.52%)
USD |
NASDAQ |
Jun 11, 11:31
CytoSorbents Total Assets (Quarterly) : 40.56M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 40.56M |
| December 31, 2025 | 47.64M |
| September 30, 2025 | 45.75M |
| June 30, 2025 | 47.99M |
| March 31, 2025 | 50.78M |
| December 31, 2024 | 50.96M |
| September 30, 2024 | 47.80M |
| June 30, 2024 | 53.43M |
| March 31, 2024 | 47.07M |
| December 31, 2023 | 56.66M |
| September 30, 2023 | 47.58M |
| June 30, 2023 | 52.44M |
| March 31, 2023 | 57.46M |
| December 31, 2022 | 63.23M |
| September 30, 2022 | 62.27M |
| June 30, 2022 | 71.21M |
| March 31, 2022 | 83.27M |
| December 31, 2021 | 89.52M |
| September 30, 2021 | 95.07M |
| June 30, 2021 | 98.19M |
| March 31, 2021 | 87.48M |
| December 31, 2020 | 89.95M |
| September 30, 2020 | 104.28M |
| June 30, 2020 | 49.26M |
| March 31, 2020 | 44.23M |
| Date | Value |
|---|---|
| December 31, 2019 | 27.38M |
| September 30, 2019 | 28.68M |
| June 30, 2019 | 28.48M |
| March 31, 2019 | 30.99M |
| December 31, 2018 | 32.75M |
| September 30, 2018 | 34.25M |
| June 30, 2018 | 34.95M |
| March 31, 2018 | 28.30M |
| December 31, 2017 | 24.10M |
| September 30, 2017 | 22.22M |
| June 30, 2017 | 22.09M |
| March 31, 2017 | 8.289M |
| December 31, 2016 | 9.694M |
| September 30, 2016 | 10.86M |
| June 30, 2016 | 12.71M |
| March 31, 2016 | 9.512M |
| December 31, 2015 | 11.25M |
| September 30, 2015 | 12.80M |
| June 30, 2015 | 14.10M |
| March 31, 2015 | 15.86M |
| December 31, 2014 | 8.469M |
| September 30, 2014 | 9.627M |
| June 30, 2014 | 11.26M |
| March 31, 2014 | 12.39M |
| December 31, 2013 | 4.046M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ClearPoint Neuro, Inc. | 93.42M |
| Abbott Laboratories | 110.43B |
| AngioDynamics, Inc. | 260.68M |
| Alphatec Holdings, Inc. | 799.48M |
| AtriCure, Inc. | 643.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 38.37M |
| Shareholders Equity (Quarterly) | 2.194M |
| Debt to Equity Ratio | 13.47 |
| Current Ratio | 1.089 |
| Net Debt Paydown Yield | -1.49% |